Michael C James bought $5,000 of GTHP
director at GUIDED THERAPEUTICS INC. 27,778 shares at an average of $0.18, traded Aug 29, 2025, filed Sep 5, 2025.
Score components
- +15RoleDirector
- 0Trade size$5k at market
- +3Relative to holdingsHoldings up 5%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -14.6%, 3m -10.7%, 6m +7.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001477932-25-006513, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 29, 2025 | POpen-market purchase Common Stock | +27,778 | $0.18 | $5,000 | 553,495 | Sep 5, 2025 |
| Aug 29, 2025 | POpen-market purchase Warrantsderivative | +27,778 | - | - | 52,778 | Sep 5, 2025 |
Related signals
Other insiders at GUIDED THERAPEUTICS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | GUIDED THERAPEUTICS INC | John E Imhoff director, owner | $30k 166,667 shares | +1% | |
| 37Weak | GUIDED THERAPEUTICS INC | John E Imhoff director, owner | $126k 1,263,069 shares | +8% | |
| 37Weak | GUIDED THERAPEUTICS INC | John E Imhoff director, owner | $126k 1,263,069 shares | +8% | |
| 39Weak | GUIDED THERAPEUTICS INC | Michael C James director | $41k 412,945 shares | +366% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.